Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Savient reaches recruitment target in gout study
However, the company intends to allow patients currently in the screening process to enroll in the phase III clinical trials if they qualify, going beyond the 200 patient
However, the company intends to allow patients currently in the screening process to enroll in the phase III clinical trials if they qualify, going beyond the 200 patient
Solvay alleged that KV Pharmaceuticals' subsidiary Ethex's promotion of its Pangestyme CN 10 and Pangestyme CN 20 pancreatic enzyme products and references to Solvay's Creon 10 and Creon
Once the FDA approves a drug for any indicated use, physicians may legally prescribe the drug for different conditions and for patients in other age groups. Over the
In October 2006, Teva settled a patent dispute with the Purdue Frederick Company and certain of its affiliates pertaining to Teva's generic version of Purdue's OxyContin tablets. The
They discovered that the pain killer was most effective for children with broken bones, bruises and sprains. Ibuprofen beat generic acetaminophen and codeine in a study of 300
“We are excited to complete what we believe is the first license and co-development deal of such an innovative investigational pharmaceutical from a China-based company. Huya's mission is
A total of 147 subjects with chronic plaque psoriasis have been enrolled and are undergoing a 12-week course of treatment with one of three different concentrations of CTA018
Initial analyses of the study results show that it met its primary objective to show that faropenem was effective in eradicating pathogens from the middle ear and to
This is the first time the Task Force has made a recommendation related to taking medicines to prevent colorectal cancer. After reviewing the latest evidence on the topic,
The study will evaluate the potential of Panzem in patients who have failed treatment with Sutent (sunitinib), as well as patients who are currently being treated with sunitinib,